Saturday, October 31, 2020

Phase 3: India inquires “Covaxin” to Biotech

Drugs Controller General of India or DCGI on Friday ordered Bharath Biotech to submit outrights of phase 2 before proceeding the latter.

Bharat Biotech has informed the phase 3 study would cover 28,500 volunteers aged 18 and above set to conduct in 19 sites – including Delhi, Mumbai, Patna, and Lucknow – across 10 states. The phase-3 clinical trial application proposed a dose of 0.5 ml on days 0 and 28- sources told.

The vaccine is being under development in collaboration with the nation’s apex medical research body — the Indian Council of Medical Research (ICMR). The Pune Serum Institute located in Mumbai is the only one been approved for phase 3 study.

Related articles

In acess of 80 Million Cast Votes In Early Voting In US

More than 80 million Americans have cast ballots in the U.S. presidential election, according to a tally on Thursday from the U.S. Elections Project at the University of Florida, setting the stage...

File new discrimination lawsuit at McDonald’s by Black franchisees

McDonald’s had a great hit on Thursday with a potentially multi-billion-dollar lawsuit by Black franchise owners who accused the fast-food giant of racial discrimination for steering them to underperforming stores.

Starbucks earnings reached top estimates as sales recover quicker than await in U.S. , China

Sales in the U.S. and China are recovering from the coronavirus pandemic more quickly than expected, helping global same-store sales shrink just 9% on Thursday reported by Starbucks. The...

Foreign investors drive over $1 billion into Asian bonds in September

Novartis' Q3 core net income surges to $3.47 billion Capgemini reports 18.4% rise in Q3 sales; digital, cloud services grow over 10%. Higher yields and some signs of economic...

Japan’s exports grasp amid slow recovery from COVID-19 drop-off

Japan's exports fell too slow in September in a sign that trade damage from the coronavirus pandemic is easing, according to Finance Ministry data released on Monday.  The report...